We are not a distributor and not a subsidiary. We own the products we sell, the quality system behind them and the field organization that places them.
Surgnovation runs from the Washington D.C. metro area, with commercial operations in the United States dating to 2009. Over that period we have built the pieces that normally sit outside a company of our size: a registered establishment with its own quality system, a machining and assembly operation, an engineering group covering electrical, mechanical and software, and a direct field sales organization with its own service infrastructure.
The reason is straightforward. In surgical devices, the gap between a good product and a placed product is regulatory work, clinical evidence, hospital contracting and service coverage. Companies that outsource those functions lose control of their own timeline. We chose to carry them.
It also means the same infrastructure can carry more than one product line. Adding a second or third line does not require a second regulatory team, a second field force or a second service base — which is why we are able to work with partner brands as well as our own portfolio.
Risk management, design history files and post-market surveillance run as standing processes with named owners — not as documentation assembled before an audit.
Every placed unit carries its own service, calibration and complaint history. If a device is questioned, we can answer with records rather than recollection.
What we tell a surgeon is what we can support. Marketing language is reviewed against cleared indications, and our field team is trained on where the boundary sits.
Production, test and calibration happen in a facility our engineers work in. Supplier changes go through qualification, not a purchase order.
Loaner pool, calibration base and field service scheduling are staffed internally, because a console that is down is a product that is failing.
Shared regulatory, quality, manufacturing and commercial functions mean a new product line inherits a working system instead of starting one.
We work with hospitals and ASCs directly, and with device manufacturers who want their technology commercialized in markets where they have no infrastructure of their own.